<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Shahid Sadoughi University of Medical Sciences</PublisherName>
				<JournalTitle>Journal of Integrated Maternal and Pediatric Care</JournalTitle>
				<Issn>3134-0792</Issn>
				<Volume>3</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2020</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Amniocentesis Complications in Yazd Baghaeipour Polyclinic: A Cross-Sectional Study</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>12</FirstPage>
			<LastPage>18</LastPage>
			<ELocationID EIdType="pii">107</ELocationID>
			
<ELocationID EIdType="doi">10.18502/wjpn.v3i1.5061</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Nasim</FirstName>
					<LastName>Shirgholami</LastName>
<Affiliation>Ali ben Abitaleb Medical School, Islamic Azad University, Yazd, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Fatemeh</FirstName>
					<LastName>Abdi</LastName>
<Affiliation>Department of Medical Genetics, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-0424-3379</Identifier>

</Author>
<Author>
					<FirstName>Mahta</FirstName>
					<LastName>Mazaheri</LastName>

						<AffiliationInfo>
						<Affiliation>Department of Medical Genetics, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Mother and Newborn Health Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0003-4164-3400</Identifier>

</Author>
<Author>
					<FirstName>Razieh Sadat</FirstName>
					<LastName>Tabatabaee</LastName>

						<AffiliationInfo>
						<Affiliation>Department of Obstetrics and Gynecology, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</Affiliation>
						</AffiliationInfo>

						<AffiliationInfo>
						<Affiliation>Mother and Newborn Health Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran</Affiliation>
						</AffiliationInfo>
<Identifier Source="ORCID">0000-0003-4835-3545</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>12</Month>
					<Day>30</Day>
				</PubDate>
			</History>
		    <Abstract>Background: Amniocentesis, like other invasive methods, has complications such as abortion, premature rupture - second pregnancy and at 29 weeks of membranes, infection, bleeding, etc. Here, we aimed to study the complications of amniocentesis in pregnant women.
Methods: This descriptive cross-sectional study was included 409 women with positive first and second stage screening or required amniocentesis referred to Baghaeipour Clinic in 2017. Data was collected by a pre-prepared questionnaire.
Results: The mean age of the patients and gestational age was  33.49 ± 6.51 years and 17.39 ± 1.36  weeks, respectively. 132 patients (32.2%) had a history of abortion. Regarding the frequency of needle passage through the placenta, the results showed that in 369 people (90.2%) the needle did not pass through the placenta and in 40 people (9.8%). The needle has passed through the pair. Regarding the frequency distribution of amniocentesis complications, fetal death in (2.4%), bleeding in (2.2%) and PROM (1.7%) were observed in patients and no case of infection and abortion was observed. In terms of age, gestational age, gestational number, placental location, needle passage, aspirated fluid color, history of abortion and type of delivery, there were no significant differences.
Conclusion: In this study the most common complication of amniocentesis was fetal death (2.4%), followed by bleeding and Spotting (2.2%), PROM (1.7%), infection and abortion, respectively.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Amniocentesis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Complications</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Abortion</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Fetal Death</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jimpc.ssu.ac.ir/article_107_a97da629b098b75c294dffdc3e463904.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
